Adherence
WEST, CARD, PROSTATE
We asked participants to refrain from vaginal or anal intercourse, douching, and use of all intravaginal objects and products starting 48 hours before baseline sampling at V2 through 5 days after the visit, and again starting 48 hours before V3 through 5 days after the last biopsy collection. We confirmed the absence of vaginal semen at V2 and V3 with a point-of-care prostate specific antigen test (ABA Card, Abacus Diagnostics, West Hill, CA). All participants inserted the vaginal product in the clinic.